206 related articles for article (PubMed ID: 32294338)
1. Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States.
Spinelli MA; Laborde N; Kinley P; Whitacre R; Scott HM; Walker N; Liu AY; Gandhi M; Buchbinder SP
J Int AIDS Soc; 2020 Apr; 23(4):e25472. PubMed ID: 32294338
[TBL] [Abstract][Full Text] [Related]
2. PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.
Cooney EE; Saleem HT; Stevenson M; Aguayo-Romero RA; Althoff KN; Poteat TC; Beckham SW; Adams D; Radix AE; Wawrzyniak AJ; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Mayer KH; Beyrer C; Reisner SL; Wirtz AL;
J Int AIDS Soc; 2023 Dec; 26(12):e26199. PubMed ID: 38123897
[TBL] [Abstract][Full Text] [Related]
3. Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California.
Prescott MR; Hern J; Petersen M; Santos GM
AIDS Patient Care STDS; 2019 Apr; 33(4):167-174. PubMed ID: 30932698
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with PrEP-era HIV seroconversion in a 4-year U.S. national cohort of n = 6059 sexual and gender minority individuals who have sex with men, 2017-2022.
Grov C; Guo Y; Westmoreland DA; D'Angelo AB; Mirzayi C; Dearolf M; Carneiro P; Ray M; Pantalone D; Carrico AW; Patel VV; Golub SA; Hirshfield S; Hoover DR; Nash D
J Int AIDS Soc; 2024 Jun; 27(6):e26312. PubMed ID: 38924359
[TBL] [Abstract][Full Text] [Related]
5. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
6. Understanding PrEP Persistence: Provider and Patient Perspectives.
Laborde ND; Kinley PM; Spinelli M; Vittinghoff E; Whitacre R; Scott HM; Buchbinder SP
AIDS Behav; 2020 Sep; 24(9):2509-2519. PubMed ID: 32048078
[TBL] [Abstract][Full Text] [Related]
7. Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004-2014.
Chen YH; Snowden JM; McFarland W; Raymond HF
AIDS Behav; 2016 Dec; 20(12):2791-2797. PubMed ID: 26983951
[TBL] [Abstract][Full Text] [Related]
8. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco.
Shen M; Xiao Y; Rong L; Meyers LA; Bellan SE
BMC Med; 2018 Apr; 16(1):58. PubMed ID: 29688862
[TBL] [Abstract][Full Text] [Related]
10. Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men.
Le Guillou A; Buchbinder S; Scott H; Liu A; Havlir D; Scheer S; Jenness SM
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):340-347. PubMed ID: 34354011
[TBL] [Abstract][Full Text] [Related]
11. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: implications for disparities.
Snowden JM; Chen YH; McFarland W; Raymond HF
Sex Transm Infect; 2017 Feb; 93(1):52-55. PubMed ID: 27356041
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW).
Dharan NJ; Jin F; Vaccher S; Bavinton B; Yeung B; Guy R; Carr A; Zablotska I; Amin J; Read P; Templeton DJ; Ooi C; Martin SJ; Ryder N; Smith DE; McNulty A; Brown K; Price K; Holden J; Grulich AE;
Clin Infect Dis; 2023 Feb; 76(3):e622-e628. PubMed ID: 35982613
[TBL] [Abstract][Full Text] [Related]
14. Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa.
Laurent C; Yaya I; Cuer B; Sagaon-Teyssier L; Mensah E; Dah TTE; Coulibaly A; Kouamé MJ; Peytavin G; Serrano L; Eubanks A; Traoré I; Diallo F; Riegel L; Rojas Castro D; Dagnra CA; Anoma C; Vuylsteke B; Dembélé Keita B; Spire B;
Clin Infect Dis; 2023 Aug; 77(4):606-614. PubMed ID: 37052469
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of multiple data sources for predicting increased need for HIV prevention among cisgender women: understanding missed opportunities for Pre-exposure Prophylaxis (PrEP).
Johnson AK; Devlin S; Haider S; Oehler C; Rivera J; Alvarez I; Ridgway J
BMC Infect Dis; 2023 Nov; 23(1):781. PubMed ID: 37946103
[TBL] [Abstract][Full Text] [Related]
16. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D;
Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
[TBL] [Abstract][Full Text] [Related]
18. The importance of PrEP persistence in preventing HIV infections on PrEP.
Spinelli MA; Laborde N; Kinley P; Whitacre R; Scott HM; Walker N; Liu AY; Gandhi M; Buchbinder SP
J Int AIDS Soc; 2020 Aug; 23(8):e25578. PubMed ID: 32844591
[No Abstract] [Full Text] [Related]
19. Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018.
McFarland W; Lin J; Santos GM; Arayasirikul S; Raymond HF; Wilson E
AIDS Behav; 2020 May; 24(5):1290-1293. PubMed ID: 31563984
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
